<DOC>
	<DOCNO>NCT01316224</DOCNO>
	<brief_summary>Psoriatic Arthritis ( PsA ) comorbidity affect significant proportion participant moderate severe psoriasis . The purpose study describe profile patient moderate severe plaque psoriasis ( Ps ) Colombia evaluate adalimumab efficacy safety profile .</brief_summary>
	<brief_title>Prevalence Incidence Articular Symptoms Signs Related Psoriatic Arthritis Patients With Psoriasis Severe Moderate With Adalimumab Treatment</brief_title>
	<detailed_description>Psoriasis chronic inflammatory disease affect 1 % 3 % population worldwide . A significant portion ( 5 % -40 % ) participant psoriasis develop PsA , chronic inflammatory arthritis cause progressive joint damage , reduced functionality increase mortality risk . Skin disease typically manifest arthritis 80 % PsA participant , psoriasis symptom usually precede joint symptom average 10 year . Participants psoriasis comorbid PsA incur substantially increase cost care experience great impairment physical functioning quality life compare participant psoriasis alone .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Signs Symptoms</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Participant document clinical diagnosis psoriasis , determine participant interview his/her medical history confirmation diagnosis physical examination investigator Participant indication psoriasis systemic therapy If female , participant either childbearing potential , defined postmenopausal least 1 year surgically sterile ( bilateral tubal ligation , bilateral oophorectomy hysterectomy ) , childbearing potential practice one follow method birth control : Condoms , sponge , foam , jelly , diaphragm intrauterine device ( IUD ) Contraceptives ( oral parenteral ) three month ( 90 day ) prior study drug administration A vasectomize partner Total abstinence sexual intercourse Able willing give write informed consent comply requirement study protocol Participants active infection Participants enrol another study clinical trial Any condition accord criterion participate investigator represent obstacle study conduction and/or participant unacceptable risk History active tuberculosis ( TB ) , histoplasmosis listeriosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Psoriasis</keyword>
	<keyword>Incidence</keyword>
	<keyword>Quality Life</keyword>
	<keyword>Psoriatic Arthritis</keyword>
	<keyword>Prevalence</keyword>
</DOC>